TG-MVA Development of an MVA-based prophylactic vaccine candidate against mpox.
Download the fact sheet
Transgene to Present Preclinical Data Demonstrating Robust Protection Against Mpox with its Novel Scalable Cell Line-Derived MVA Vaccine Cadidate (TG-MVA) at WCID 2026.
Download the press release
N. Silvestre, et al.
World Congress on Infectious Diseases WCID 2026 – Abstract available on the WCID website – Download the abstract – Download the oral presentation